Distribution of FVIII levels after valoctocogene roxaparvovec. Factor VIII activity is reported by OSA that is either directly reported or 1.6-fold higher than reported CSA determined FVIII activity. (A) Distribution after 1 year. (B) Proportion of phase 3 participants with FVIII levels by hemophilia severity.